EM2107F "Using Biomarkers to Add Precision to Cardiovascular Medicine, Prevention and Population Health: Hype or Hope?" (IM GR073021)
The purpose of this lecture is to review challenges and progress towards the vision of precision therapeutics in cardiovascular prevention. The focus of the lecture will be on the role of cardiovascular biomarkers for risk assessment and selection of preventive strategies among individuals in the population. Potential future roles of augmented risk assessment using biomarkers for a “precision-like” prevention and population health approach will be discussed.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- identify the limitations of currently available cardiovascular risk assessment and precision medicine tools.
- review the strengths and limitations of currently available biomarkers, including c-reactive protein, troponins and natriuretic peptides, for risk assessment and therapeutic guidance in cardiovascular prevention.
- describe actuarial risk assessment for specific cardiovascular outcomes to help guide decisions for CVD prevention and treatment.
- understand how improved risk assessment may enhance population health efforts.
James de Lemos, M.D.
Professor, Department of Internal Medicine
Division of Cardiology Cardiology
Service Chief – PHHS
Director of Cardiac Care Unit – PHHS
- 1.00 AMA